Portfolio Holdings Detail for ISIN IE00BP3QZ601
Stock Name / FundiShares MSCI World Quality Factor UCITS
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerIWFQ(GBX) LSE
ETF TickerIS3Q(EUR) F
ETF TickerIS3Q.DE(EUR) CXE
ETF TickerIWFQ.LS(GBX) CXE
ETF TickerIWQU.LS(USD) CXE
ETF TickerIWQU.MI(EUR) CXE
ETF TickerIWQU(EUR) ETF Plus
ETF TickerIWFQ.L(GBP) LSE

Holdings detail for VRTX

Stock NameVertex Pharmaceuticals Inc
TickerVRTX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS92532F1003
LEI54930015RAQRRZ5ZGJ91

Show aggregate VRTX holdings

News associated with VRTX

Vertex Pharmaceuticals (NASDAQ:VRTX) Rating Increased to Buy at StockNews.com
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Tuesday. A number of other equities analysts have also weighed in on VRTX. HC Wainwright reiterated a “buy” rating and issued a $550.00 price target on shares of […] - 2025-03-13 06:26:55
Rep. Jefferson Shreve Purchases Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Representative Jefferson Shreve (R-Indiana) recently bought shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). In a filing disclosed on March 09th, the Representative disclosed that they had bought between $15,001 and $50,000 in Vertex Pharmaceuticals stock on February 24th. The trade occurred in the Representative’s “CRT – STANDARD UNIT TRUST” account. Representative Jefferson Shreve also recently made […] - 2025-03-12 06:04:59
IVW, AXP, FI, VRTX: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares S&P 500 Growth ETF (Symbol: IVW) where we have detected an approximate $306.8 million dollar outflow -- that's a 0.6% decrease week over - 2025-03-11 15:28:55
Company News for Mar 11, 2025
Companies in The News Are: VRTX, TSLA, NVDA, COIN - 2025-03-11 13:22:00
Nasdaq Correction: The 2 Smartest Stocks to Buy and Hold Forever
When you're on an airplane, the pilot or a flight attendant will typically announce over the loudspeaker to "buckle your seatbelt" when the air is turbulent. That could be good advice for investors right now, too. - 2025-03-11 09:31:00
Where Will Vertex Pharmaceuticals Be in 10 Years?
The past decade has been a game-changing one for Vertex Pharmaceuticals (NASDAQ: VRTX). The biotech won approval for its first cystic fibrosis (CF) drug -- Kalydeco -- back in 2012 and has since gained the regulatory nod for four more and become the global leader in the CF market - 2025-03-11 08:25:00
5 Top Stocks to Buy in March
2025 has gotten off to a choppy start as some of the most valuable U.S.-based companies are dragging down the major stock market indexes. But getting caught up in short-term market movements is a mistake. - 2025-03-04 11:15:00
XLV, SYK, DHR, VRTX: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $434.3 million dollar outflow -- that's a 1.1% decrease - 2025-02-21 16:22:43
Vertex Pharmaceuticals (NASDAQ:VRTX) Lowered to Hold Rating by StockNews.com
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Wednesday. VRTX has been the subject of a number of other reports. Scotiabank raised their price objective on Vertex Pharmaceuticals from $433.00 to $450.00 and gave the stock […] - 2025-02-21 06:55:07
Are Wall Street Analysts Predicting Vertex Pharmaceuticals Stock Will Climb or Sink?
Vertex Pharmaceuticals has lagged behind the broader market over the past year, and Wall Street analysts are cautiously optimistic about the stock’s future. - 2025-02-20 14:51:41
Blue Trust Inc. Sells 2,077 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Blue Trust Inc. lowered its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 76.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 634 shares of the pharmaceutical company’s stock after selling 2,077 shares during the period. Blue […] - 2025-02-19 09:02:04
IUSG, ANET, VRTX, PH: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core S&P U.S. Growth ETF (Symbol: IUSG) where we have detected an approximate $324.0 million dollar outflow -- that's a 1.5% decrease we - 2025-02-13 15:47:21
Vertex Pharmaceuticals (NASDAQ:VRTX) Given “Hold” Rating at Needham & Company LLC
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report)‘s stock had its “hold” rating restated by research analysts at Needham & Company LLC in a research report issued on Tuesday,Benzinga reports. Other equities analysts have also issued reports about the stock. Citigroup started coverage on shares of Vertex Pharmaceuticals in a research report on Thursday, November 14th. […] - 2025-02-13 09:32:55
Vertex Pharmaceuticals (NASDAQ:VRTX) Given New $467.00 Price Target at Barclays
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price target hoisted by analysts at Barclays from $435.00 to $467.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm presently has an “equal weight” rating on the pharmaceutical company’s stock. Barclays‘s price objective suggests a potential upside of 3.05% from […] - 2025-02-13 09:32:50
Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $520.00
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price objective upped by equities researchers at Truist Financial from $460.00 to $520.00 in a research report issued on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the pharmaceutical company’s stock. Truist Financial’s price target suggests a potential upside of 14.74% from the company’s […] - 2025-02-13 08:42:49
Fund Update: ALLIANCEBERNSTEIN L.P. Just Disclosed New Holdings
ALLIANCEBERNSTEIN L.P. just filed a portfolio update, which we received from a 13F disclosure. This disclosure reflects the funds' holdings for the 12-31-2024 report period. You can see the full portfolio on Quiver Quantitative, and track moves made by other funds. - 2025-02-12 19:56:04
Vertex: Strong Sales, Stronger Pipeline
Here's our initial take on Vertex Pharmaceuticals' (NASDAQ: VRTX) fourth-quarter financial report.Key Metrics Metric Q4 2023 Q4 2024 Change vs. Expectations Revenue $2.52 billion $2.91 billion 16% Beat Earnings per share $3.71 $3.50 -6% Missed Trikafta/Kaftrio revenue $ - 2025-02-11 14:15:00
Fund Update: PARNASSUS INVESTMENTS, LLC Just Disclosed New Holdings
PARNASSUS INVESTMENTS, LLC just filed a portfolio update, which we received from a 13F disclosure. This disclosure reflects the funds' holdings for the 12-31-2024 report period. You can see the full portfolio on Quiver Quantitative, and track moves made by other funds. - 2025-02-10 15:42:57
Earnings Season Scorecard and Analyst Reports for Meta Platforms, Mastercard & Adobe
A real-time update on the Q4 earnings season is included in today's Research Daily, in addition to featuring updated analyst reports on Meta Platforms (META), Mastercard (MA), Adobe (ADBE) and others. - 2025-02-04 17:49:00
Schwab U.S. Large-Cap Growth ETF Experiences Big Inflow
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Schwab U.S. Large-Cap Growth ETF (Symbol: SCHG) where we have detected an approximate $315.4 million dollar inflow -- that's a 0.8% increase week ove - 2025-02-04 16:04:54
Stocks Retreat on Tariff Anxiety
The S&P 500 Index ($SPX ) (SPY ) Friday closed down -0.50%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.14%. March E-mini S&P futures (ESH25 ) are down by -0.53%, and March E-mini Nasdaq... - 2025-02-03 14:54:37
Stocks Retreat on Tariff Anxiety
The S&P 500 Index ($SPX ) (SPY ) Friday closed down -0.50%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.14%. March E-mini S&P futures (ESH25 ) are down by -0.53%, and March E-mini Nasdaq... - 2025-02-03 14:21:10
Stocks Retreat on Tariff Anxiety
The S&P 500 Index ($SPX ) (SPY ) Friday closed down -0.50%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.14%. March E-mini S&P futures (ESH25 ) are down by -0.53%, and March E-mini Nasdaq... - 2025-02-03 12:52:57
Stocks Retreat on Tariff Anxiety
The S&P 500 Index ($SPX ) (SPY ) Friday closed down -0.50%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.14%. March E-mini S&P futures (ESH25 ) are down by -0.53%, and March E-mini Nasdaq... - 2025-02-03 12:23:28
Scotiabank Issues Positive Forecast for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Price
Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its target price hoisted by Scotiabank from $430.00 to $433.00 in a research note released on Friday morning,Benzinga reports. The brokerage currently has a sector perform rating on the pharmaceutical company’s stock. Several other research analysts have also issued reports on VRTX. Morgan Stanley upped their target price […] - 2025-02-03 07:01:06
Vertex Pharmaceuticals (NASDAQ:VRTX) Receives “Overweight” Rating from Cantor Fitzgerald
Cantor Fitzgerald restated their overweight rating on shares of Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) in a research report released on Friday,Benzinga reports. Cantor Fitzgerald currently has a $480.00 price target on the pharmaceutical company’s stock. VRTX has been the topic of a number of other reports. Wells Fargo & Company cut shares of Vertex […] - 2025-02-03 07:01:05
HC Wainwright Forecasts Strong Price Appreciation for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock
Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its target price lifted by HC Wainwright from $535.00 to $550.00 in a research report sent to investors on Friday,Benzinga reports. HC Wainwright currently has a buy rating on the pharmaceutical company’s stock. A number of other analysts have also weighed in on VRTX. Citigroup began coverage on […] - 2025-02-03 07:01:05
Stocks Retreat on Tariff Anxiety
The S&P 500 Index ($SPX ) (SPY ) Friday closed down -0.50%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.14%. March E-mini S&P futures (ESH25 ) are down by -0.53%, and March E-mini Nasdaq... - 2025-02-03 06:11:06
Should You Pick VRTX Stock At $450?
Vertex Pharmaceuticals stock (NASDAQ: VRTX) is trending higher after the U.S. FDA approved Journavx – an oral non-opioid pain medication. This is a big win for Vertex, given that Journavx can potentially garner $4 billion in annual peak sales. For perspective, Vertex’ - 2025-02-03 03:17:52
Stocks Retreat in Afternoon Trading
This afternoon, the S&P 500 Index ($SPX ) (SPY ) is down -0.48%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.71%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up -0.36%. Stocks are moving lower this afternoon, after the Dow Jones Industrials posted an... - 2025-02-01 00:40:50

iShares MSCI World Quality Factor UCITS VRTX holdings

DateNumber of VRTX Shares HeldBase Market Value of VRTX SharesLocal Market Value of VRTX SharesChange in VRTX Shares HeldChange in VRTX Base ValueCurrent Price per VRTX Share HeldPrevious Price per VRTX Share Held
2025-03-12 (Wednesday)25,047USD 12,408,785VRTX holding increased by 177333USD 12,408,7850USD 177,333 USD 495.42 USD 488.34
2025-03-11 (Tuesday)25,047VRTX holding decreased by -86USD 12,231,452VRTX holding decreased by -335299USD 12,231,452-86USD -335,299 USD 488.34 USD 500.01
2025-03-10 (Monday)25,133USD 12,566,751VRTX holding increased by 294558USD 12,566,7510USD 294,558 USD 500.01 USD 488.29
2025-03-07 (Friday)25,133USD 12,272,193VRTX holding decreased by -84195USD 12,272,1930USD -84,195 USD 488.29 USD 491.64
2025-03-05 (Wednesday)25,133USD 12,356,388VRTX holding increased by 136221USD 12,356,3880USD 136,221 USD 491.64 USD 486.22
2025-03-04 (Tuesday)25,133USD 12,220,167VRTX holding increased by 73137USD 12,220,1670USD 73,137 USD 486.22 USD 483.31
2025-03-03 (Monday)25,133USD 12,147,030VRTX holding increased by 88468USD 12,147,0300USD 88,468 USD 483.31 USD 479.79
2025-02-28 (Friday)25,133USD 12,058,562VRTX holding increased by 132953USD 12,058,5620USD 132,953 USD 479.79 USD 474.5
2025-02-27 (Thursday)25,133USD 11,925,609VRTX holding decreased by -115611USD 11,925,6090USD -115,611 USD 474.5 USD 479.1
2025-02-26 (Wednesday)25,133VRTX holding decreased by -86USD 12,041,220VRTX holding decreased by -72727USD 12,041,220-86USD -72,727 USD 479.1 USD 480.35
2025-02-25 (Tuesday)25,219USD 12,113,947VRTX holding decreased by -32784USD 12,113,9470USD -32,784 USD 480.35 USD 481.65
2025-02-24 (Monday)25,219USD 12,146,731VRTX holding decreased by -65318USD 12,146,7310USD -65,318 USD 481.65 USD 484.24
2025-02-21 (Friday)25,219USD 12,212,049VRTX holding increased by 98607USD 12,212,0490USD 98,607 USD 484.24 USD 480.33
2025-02-20 (Thursday)25,219USD 12,113,442VRTX holding increased by 216127USD 12,113,4420USD 216,127 USD 480.33 USD 471.76
2025-02-19 (Wednesday)25,219USD 11,897,315VRTX holding increased by 243363USD 11,897,3150USD 243,363 USD 471.76 USD 462.11
2025-02-18 (Tuesday)25,219USD 11,653,952VRTX holding increased by 78431USD 11,653,9520USD 78,431 USD 462.11 USD 459
2025-02-17 (Monday)25,219USD 11,575,521USD 11,575,5210USD 0 USD 459 USD 459
2025-02-14 (Friday)25,219VRTX holding decreased by -86USD 11,575,521VRTX holding decreased by -130066USD 11,575,521-86USD -130,066 USD 459 USD 462.58
2025-02-13 (Thursday)25,305USD 11,705,587VRTX holding increased by 237361USD 11,705,5870USD 237,361 USD 462.58 USD 453.2
2025-02-12 (Wednesday)25,305USD 11,468,226VRTX holding decreased by -51116USD 11,468,2260USD -51,116 USD 453.2 USD 455.22
2025-02-11 (Tuesday)25,305USD 11,519,342VRTX holding decreased by -373249USD 11,519,3420USD -373,249 USD 455.22 USD 469.97
2025-02-10 (Monday)25,305USD 11,892,591VRTX holding increased by 16448USD 11,892,5910USD 16,448 USD 469.97 USD 469.32
2025-02-07 (Friday)25,305USD 11,876,143VRTX holding decreased by -299611USD 11,876,1430USD -299,611 USD 469.32 USD 481.16
2025-02-06 (Thursday)25,305USD 12,175,754VRTX holding decreased by -184220USD 12,175,7540USD -184,220 USD 481.16 USD 488.44
2025-02-05 (Wednesday)25,305USD 12,359,974VRTX holding increased by 155879USD 12,359,9740USD 155,879 USD 488.44 USD 482.28
2025-02-04 (Tuesday)25,305USD 12,204,095VRTX holding increased by 301382USD 12,204,0950USD 301,382 USD 482.28 USD 470.37
2025-02-03 (Monday)25,305USD 11,902,713VRTX holding increased by 219901USD 11,902,7130USD 219,901 USD 470.37 USD 461.68
2025-01-31 (Friday)25,305USD 11,682,812VRTX holding increased by 589100USD 11,682,8120USD 589,100 USD 461.68 USD 438.4
2025-01-30 (Thursday)25,305USD 11,093,712VRTX holding decreased by -78952USD 11,093,7120USD -78,952 USD 438.4 USD 441.52
2025-01-29 (Wednesday)25,305USD 11,172,664VRTX holding increased by 21257USD 11,172,6640USD 21,257 USD 441.52 USD 440.68
2025-01-28 (Tuesday)25,305USD 11,151,407VRTX holding decreased by -80976USD 11,151,4070USD -80,976 USD 440.68 USD 443.88
2025-01-27 (Monday)25,305USD 11,232,383VRTX holding increased by 107799USD 11,232,3830USD 107,799 USD 443.88 USD 439.62
2025-01-24 (Friday)25,305USD 11,124,584VRTX holding decreased by -2784USD 11,124,5840USD -2,784 USD 439.62 USD 439.73
2025-01-23 (Thursday)25,305USD 11,127,368VRTX holding increased by 296828USD 11,127,3680USD 296,828 USD 439.73 USD 428
2025-01-22 (Wednesday)25,305USD 10,830,540USD 10,830,540
2025-01-21 (Tuesday)25,305USD 10,827,756USD 10,827,756
2025-01-20 (Monday)25,305USD 10,678,710USD 10,678,710
2025-01-17 (Friday)25,305USD 10,678,710USD 10,678,710
2025-01-16 (Thursday)25,305USD 10,551,173USD 10,551,173
2025-01-15 (Wednesday)25,305USD 10,735,899USD 10,735,899
2025-01-14 (Tuesday)25,218USD 10,381,242USD 10,381,242
2025-01-13 (Monday)25,218USD 10,424,365USD 10,424,365
2025-01-10 (Friday)25,218USD 10,328,284USD 10,328,284
2025-01-09 (Thursday)25,218USD 10,392,590USD 10,392,590
2025-01-09 (Thursday)25,218USD 10,392,590USD 10,392,590
2025-01-09 (Thursday)25,218USD 10,392,590USD 10,392,590
2025-01-08 (Wednesday)25,218USD 10,392,590USD 10,392,590
2025-01-08 (Wednesday)25,218USD 10,392,590USD 10,392,590
2025-01-08 (Wednesday)25,218USD 10,392,590USD 10,392,590
2025-01-02 (Thursday)25,044VRTX holding increased by 346USD 10,161,853VRTX holding decreased by -1426943USD 10,161,853346USD -1,426,943 USD 405.76 USD 469.22
2024-12-30 (Monday)25,044USD 10,001,321USD 10,001,321
2024-12-10 (Tuesday)24,698USD 11,588,796VRTX holding decreased by -117562USD 11,588,7960USD -117,562 USD 469.22 USD 473.98
2024-12-09 (Monday)24,698VRTX holding decreased by -174USD 11,706,358VRTX holding increased by 213007USD 11,706,358-174USD 213,007 USD 473.98 USD 462.1
2024-12-06 (Friday)24,872VRTX holding decreased by -946USD 11,493,351VRTX holding decreased by -380864USD 11,493,351-946USD -380,864 USD 462.1 USD 459.92
2024-12-05 (Thursday)25,818VRTX holding decreased by -86USD 11,874,215VRTX holding decreased by -144723USD 11,874,215-86USD -144,723 USD 459.92 USD 463.98
2024-12-04 (Wednesday)25,904USD 12,018,938VRTX holding increased by 181587USD 12,018,9380USD 181,587 USD 463.98 USD 456.97
2024-12-03 (Tuesday)25,904VRTX holding decreased by -344USD 11,837,351VRTX holding decreased by -387130USD 11,837,351-344USD -387,130 USD 456.97 USD 465.73
2024-12-02 (Monday)26,248VRTX holding decreased by -86USD 12,224,481VRTX holding decreased by -103254USD 12,224,481-86USD -103,254 USD 465.73 USD 468.13
2024-11-29 (Friday)26,334USD 12,327,735VRTX holding increased by 94012USD 12,327,7350USD 94,012 USD 468.13 USD 464.56
2024-11-28 (Thursday)26,334USD 12,233,723USD 12,233,7230USD 0 USD 464.56 USD 464.56
2024-11-27 (Wednesday)26,334USD 12,233,723VRTX holding decreased by -66098USD 12,233,7230USD -66,098 USD 464.56 USD 467.07
2024-11-26 (Tuesday)26,334USD 12,299,821VRTX holding increased by 141150USD 12,299,8210USD 141,150 USD 467.07 USD 461.71
2024-11-25 (Monday)26,334VRTX holding decreased by -3442USD 12,158,671VRTX holding decreased by -1269412USD 12,158,671-3,442USD -1,269,412 USD 461.71 USD 450.97
2024-11-22 (Friday)29,776USD 13,428,083VRTX holding increased by 17866USD 13,428,0830USD 17,866 USD 450.97 USD 450.37
2024-11-21 (Thursday)29,776USD 13,410,217VRTX holding decreased by -25607USD 13,410,2170USD -25,607 USD 450.37 USD 451.23
2024-11-20 (Wednesday)29,776VRTX holding decreased by -196USD 13,435,824VRTX holding increased by 8068USD 13,435,824-196USD 8,068 USD 451.23 USD 448.01
2024-11-19 (Tuesday)29,972USD 13,427,756VRTX holding decreased by -569468USD 13,427,7560USD -569,468 USD 448.01 USD 467.01
2024-11-18 (Monday)29,972VRTX holding increased by 388USD 13,997,224VRTX holding decreased by -498936USD 13,997,224388USD -498,936 USD 467.01 USD 490
2024-11-12 (Tuesday)29,584USD 14,496,160VRTX holding decreased by -346724USD 14,496,1600USD -346,724 USD 490 USD 501.72
2024-11-11 (Monday)29,584USD 14,842,884VRTX holding decreased by -444352USD 14,842,8840USD -444,352 USD 501.72 USD 516.74
2024-11-08 (Friday)29,584USD 15,287,236VRTX holding increased by 422755USD 15,287,2360USD 422,755 USD 516.74 USD 502.45
2024-11-07 (Thursday)29,584VRTX holding increased by 196USD 14,864,481VRTX holding increased by 357389USD 14,864,481196USD 357,389 USD 502.45 USD 493.64
2024-11-06 (Wednesday)29,388USD 14,507,092VRTX holding decreased by -183381USD 14,507,0920USD -183,381 USD 493.64 USD 499.88
2024-11-05 (Tuesday)29,388VRTX holding increased by 98USD 14,690,473VRTX holding increased by 842161USD 14,690,47398USD 842,161 USD 499.88 USD 472.8
2024-11-04 (Monday)29,290USD 13,848,312VRTX holding increased by 49207USD 13,848,3120USD 49,207 USD 472.8 USD 471.12
2024-11-01 (Friday)29,290USD 13,799,105VRTX holding decreased by -142349USD 13,799,1050USD -142,349 USD 471.12 USD 475.98
2024-10-31 (Thursday)29,290VRTX holding increased by 97USD 13,941,454VRTX holding increased by 72444USD 13,941,45497USD 72,444 USD 475.98 USD 475.08
2024-10-30 (Wednesday)29,193USD 13,869,010VRTX holding increased by 137791USD 13,869,0100USD 137,791 USD 475.08 USD 470.36
2024-10-29 (Tuesday)29,193USD 13,731,219VRTX holding decreased by -175450USD 13,731,2190USD -175,450 USD 470.36 USD 476.37
2024-10-28 (Monday)29,193USD 13,906,669VRTX holding decreased by -38827USD 13,906,6690USD -38,827 USD 476.37 USD 477.7
2024-10-25 (Friday)29,193VRTX holding increased by 97USD 13,945,496VRTX holding increased by 214803USD 13,945,49697USD 214,803 USD 477.7 USD 471.91
2024-10-24 (Thursday)29,096VRTX holding increased by 97USD 13,730,693VRTX holding increased by 99713USD 13,730,69397USD 99,713 USD 471.91 USD 470.05
2024-10-23 (Wednesday)28,999VRTX holding increased by 97USD 13,630,980VRTX holding decreased by -94869USD 13,630,98097USD -94,869 USD 470.05 USD 474.91
2024-10-22 (Tuesday)28,902USD 13,725,849VRTX holding decreased by -91908USD 13,725,8490USD -91,908 USD 474.91 USD 478.09
2024-10-21 (Monday)28,902USD 13,817,757VRTX holding decreased by -141909USD 13,817,7570USD -141,909 USD 478.09 USD 483
2024-10-18 (Friday)28,902USD 13,959,666USD 13,959,666
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of VRTX by Blackrock for IE00BP3QZ601

Show aggregate share trades of VRTX

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-03-11SELL-86 488.340* 469.69 Profit of 40,394 on sale
2025-02-26SELL-86 479.100* 467.57 Profit of 40,211 on sale
2025-02-14SELL-86 459.000* 466.83 Profit of 40,147 on sale
2025-01-02BUY346 405.760* 472.48
2024-12-09SELL-174 473.980* 472.53 Profit of 82,221 on sale
2024-12-06SELL-946 462.100* 472.87 Profit of 447,337 on sale
2024-12-05SELL-86 459.920* 473.30 Profit of 40,704 on sale
2024-12-03SELL-344 456.970* 474.22 Profit of 163,132 on sale
2024-12-02SELL-86 465.730* 474.53 Profit of 40,810 on sale
2024-11-25SELL-3,442 461.710* 476.65 Profit of 1,640,643 on sale
2024-11-20SELL-196 451.230* 480.73 Profit of 94,223 on sale
2024-11-18BUY388 467.010* 483.46
2024-11-07BUY196 502.450* 477.53
2024-11-05BUY98 499.880* 474.03
2024-10-31BUY97 475.980* 474.31
2024-10-25BUY97 477.700* 473.74
2024-10-24BUY97 471.910* 474.35
2024-10-23BUY97 470.050* 476.50
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of VRTX

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-03-13383,807127587,42865.3%
2025-03-12332,397653481,02169.1%
2025-03-11273,529437501,40954.6%
2025-03-10342,82352597,06757.4%
2025-03-07231,760226414,25555.9%
2025-03-06333,034102506,67265.7%
2025-03-05211,79523333,31363.5%
2025-03-04269,76434456,50559.1%
2025-03-03264,333109460,34757.4%
2025-02-28290,679561483,11260.2%
2025-02-27163,115716318,29751.2%
2025-02-26147,097945243,99860.3%
2025-02-25198,750113440,22045.1%
2025-02-24194,2909399,05648.7%
2025-02-21278,90716442,43663.0%
2025-02-20307,3420562,72954.6%
2025-02-19196,482807643,48430.5%
2025-02-18241,4326,621515,10946.9%
2025-02-14218,39658385,39856.7%
2025-02-13330,30769540,75161.1%
2025-02-12253,056586490,79051.6%
2025-02-11454,2461,902682,70666.5%
2025-02-10384,962106626,41361.5%
2025-02-07311,677511469,67766.4%
2025-02-06241,3734406,94159.3%
2025-02-05412,75666655,66563.0%
2025-02-04599,47243792,18975.7%
2025-02-03617,143398887,62269.5%
2025-01-311,191,3076371,734,41268.7%
2025-01-30261,23145462,12656.5%
2025-01-29207,10685460,01445.0%
2025-01-28300,3429430,70769.7%
2025-01-27345,21857512,56567.4%
2025-01-24400,74018682,55158.7%
2025-01-23488,926117635,94676.9%
2025-01-22209,467283402,08252.1%
2025-01-21359,6985,293550,66165.3%
2025-01-17347,33310536,60764.7%
2025-01-16323,363635500,29864.6%
2025-01-15285,9852,042463,10061.8%
2025-01-14273,399656557,39349.0%
2025-01-13344,521161709,60948.6%
2025-01-10404,383363670,27860.3%
2025-01-08230,17976441,78052.1%
2025-01-07259,653805673,98138.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.